[ Price : $8.95]
FDA says a Nuwellis 12/2024 recall of certain lots of its extracorporeal blood circuits is Class 1.[ Price : $8.95]
FDA approves a Neurotech Pharmaceuticals BLA for Encelto (revakinagene taroretcel-lwey) for treating macular telangiectasia Type 2...[ Price : $8.95]
Medtronics Micro Therapeutics unit recalls its Pipeline Vantage Embolization Device with Shield Technology after it determined tha...[ Price : $8.95]
FDA approves a scPharmaceuticals supplemental NDA for Furoscix (furosemide injection) to expand the indication to include treatmen...[ Price : $8.95]
FDA reports on a 2024 workshop on using dynamic tools to enhance new drug development efficiency.[ Price : $8.95]
FDA approves both Breakthrough Device and Targeted Acceleration Pathway designations for Phantom Neuros Phantom X platform that co...[ Price : $8.95]
FDA commissioner-nominee Marty Makary pledges during his confirmation hearing to do an independent assessment on personnel before ...[ Price : $8.95]
FDA issues a medical device early alert on a Baxter recall of specified Spectrum infusion pumps.